GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » Cash Flow for Lease Financing

Dae Hwa Pharm Co (XKRX:067080) Cash Flow for Lease Financing : ₩-158 Mil (TTM As of Mar. 2025)


View and export this data going back to 2003. Start your Free Trial

What is Dae Hwa Pharm Co Cash Flow for Lease Financing?

Dae Hwa Pharm Co's Cash Flow for Lease Financing for the three months ended in Mar. 2025 was ₩-40 Mil. Dae Hwa Pharm Co's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-158 Mil.

Compared with last quarter (₩-37 Mil in Dec. 2024 ), Dae Hwa Pharm Co's Cash Flow for Lease Financing remained the same in Mar. 2025 (₩-40 Mil).

Dae Hwa Pharm Co Cash Flow for Lease Financing Historical Data

The historical data trend for Dae Hwa Pharm Co's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dae Hwa Pharm Co Cash Flow for Lease Financing Chart

Dae Hwa Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -331.16 -311.07 -299.14 -263.44 -167.10

Dae Hwa Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -49.14 -50.77 -30.34 -36.86 -40.04

Dae Hwa Pharm Co Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-158 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dae Hwa Pharm Co Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Dae Hwa Pharm Co's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Dae Hwa Pharm Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » Cash Flow for Lease Financing
Comparable Companies
XKRX:001630 XKRX:000520 XKRX:007570 XKRX:096760 XKRX:476060 XKRX:005500 XKRX:008490 XKRX:293480 XKRX:102460 XKRX:092040 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Seoul, Gangwon-do, KOR, 225-804
Website
http://www.dhpharm.co.kr
Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.

Dae Hwa Pharm Co Headlines

No Headlines